| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 93 |
| 1 | ADALIMUMAB | 90 |
| 2 | VEDOLIZUMAB | 62 |
| 3 | USTEKINUMAB | 55 |
| 4 | ADALIMUMAB-AATY | 43 |
| 5 | ADALIMUMAB-ADAZ | 43 |
| 6 | ADALIMUMAB-FKJP | 43 |
| 7 | AZATHIOPRINE | 29 |
| 8 | PREDNISONE | 26 |
| 9 | METHOTREXATE SODIUM | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOGUANINE | 5 | 0.0024 |
| 1 | AZATHIOPRINE SODIUM | 5 | 0.0020 |
| 2 | MIGALASTAT HYDROCHLORIDE | 1 | 0.0018 |
| 3 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 4 | ADALIMUMAB-FKJP | 43 | 0.0009 |
| 5 | ADALIMUMAB-AATY | 43 | 0.0009 |
| 6 | METRELEPTIN | 1 | 0.0008 |
| 7 | ADALIMUMAB-ADAZ | 43 | 0.0008 |
| 8 | VEDOLIZUMAB | 62 | 0.0007 |
| 9 | TOFACITINIB CITRATE | 8 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 137 |
| 1 | Interleukin-23 Antagonist [EPC] | 68 |
| 2 | Integrin Receptor Antagonist [EPC] | 66 |
| 3 | Corticosteroid [EPC] | 57 |
| 4 | Interleukin-12 Antagonist [EPC] | 55 |
| 5 | Purine Antimetabolite [EPC] | 29 |
| 6 | Janus Kinase Inhibitor [EPC] | 22 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 8 | Aminosalicylate [EPC] | 13 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 1 | 0.0008 |
| 1 | Integrin Receptor Antagonist [EPC] | 66 | 0.0008 |
| 2 | Interleukin-23 Antagonist [EPC] | 68 | 0.0006 |
| 3 | Interleukin-12 Antagonist [EPC] | 55 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 5 | Purine Antimetabolite [EPC] | 29 | 0.0003 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 137 | 0.0001 |
| 7 | Janus Kinase Inhibitor [EPC] | 22 | 0.0001 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Bile Acid [EPC] | 3 | 0.0001 |